BDBM801010 US12590070, Compound 30::adamantan-1-carboxamide

SMILES CNC(=O)c1cccc(C)c1Nc1nc(Nc2ccc(NC(=O)[C@]34CC5CC(C3)[C@@H](N3CC[C@H](N)C3)C(C5)C4)cc2OC)ncc1C(F)(F)F

InChI Key InChIKey=RJFLDJPJXMSFNY-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 801010   

TargetProtein-tyrosine kinase 2-beta(Human)
Samjin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 801010BDBM801010(adamantan-1-carboxamide | US12590070, Compound 30)
Affinity DataIC50: 18.2nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/10/2026
Entry Details
US Patent

TargetInsulin receptor(Human)
Samjin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 801010BDBM801010(adamantan-1-carboxamide | US12590070, Compound 30)
Affinity DataIC50: 3.80E+3nMAssay Description:The inhibitory activity of the adamantane derivative compounds of the present invention to FAK, Pyk2 and InsR was confirmed through a biochemical kin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/10/2026
Entry Details
US Patent